<DOC>
	<DOCNO>NCT02799654</DOCNO>
	<brief_summary>In Post Market Clinical Follow-up Study ( PMCF Study ) , short-term clinical radiological result cementless Excia T® prosthesis routine clinical use shall assess migration take place first 24 month evaluate .</brief_summary>
	<brief_title>Excia T Cementless EBRA Study</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Written patient consent study participation Age &gt; 18 year Indication primary THA cementless Excia T® stem Pregnancy THA fracture Rheumatoid arthritis Systemic disorder , treat Cortisone pharmaceutical , potentially compromise bone quality Patient physically mentally able follow postoperative examination routine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Total Hip Arthroplasty</keyword>
</DOC>